Rovalpituzumab MMAE Antibody
Rovalpituzumab-MMAE is an anti-DLL3 antibody-drug conjugate (ADC) produced in CHO cells, with a predicted molecular weight of 145.02 kDa. This research-grade ADC is utilized in preclinical studies to investigate targeted therapies for small cell lung cancer (SCLC) in both in vitro and in vivo models.
Product Specifications
Target
Gamma-secretase
Conjugation
Unconjugated
Field of Research
Neuroscience, Protein Biochemistry, Stem Cell & Developmental Biology
Molecular Weight
145 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1197521-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O7:K1 DNA-directed RNA polymerase subunit omega (rpoZ)
Sign In for Pricing
View Details MBS1197521-02 0.1 mg (E-Coli)
Recombinant Escherichia coli O7:K1 DNA-directed RNA polymerase subunit omega (rpoZ)
Sign In for Pricing
View Details MBS1197521-03 0.02 mg (Yeast)
Recombinant Escherichia coli O7:K1 DNA-directed RNA polymerase subunit omega (rpoZ)
Sign In for Pricing
View Details MBS1197521-04 0.1 mg (Yeast)
Recombinant Escherichia coli O7:K1 DNA-directed RNA polymerase subunit omega (rpoZ)
Sign In for Pricing
View Details MBS1197521-05 0.02 mg (Baculovirus)
Recombinant Escherichia coli O7:K1 DNA-directed RNA polymerase subunit omega (rpoZ)
Sign In for Pricing
View Details MBS1197521-06 1 mg (E-Coli)
Recombinant Escherichia coli O7:K1 DNA-directed RNA polymerase subunit omega (rpoZ)
Sign In for Pricing
View Details